Background: Plazomicin is a derivative of sisomicin and a next-generation aminoglycoside currently under clinical development for the treatment of gram-negative bacterial infections. Objective: To determine the effect of plazomicin as a treatment for Enterobacteria infections in hospitalized patients. Materials and Methods: Studies were selected from PubMed, Scopus, Cochrane, and Google Scholar. D...
Background: Plazomicin is a derivative of sisomicin and a next-generation aminoglycoside currently under clinical development for the treatment of gram-negative bacterial infections. Objective: To determine the effect of plazomicin as a treatment for Enterobacteria infections in hospitalized patients. Materials and Methods: Studies were selected from PubMed, Scopus, Cochrane, and Google Scholar. D...